Premium
In HIV‐infected individuals who desire combination antiviral therapy, zidovudine plus didanosine is preferred to zidovudine plus zalcitabine
Author(s) -
Montaner J. S. G.,
Wainberg M. A.,
O'Shaughnessy M. V.
Publication year - 1994
Publication title -
reviews in medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.06
H-Index - 90
eISSN - 1099-1654
pISSN - 1052-9276
DOI - 10.1002/rmv.1980040105
Subject(s) - didanosine , zalcitabine , zidovudine , excellence , columbia university , medicine , family medicine , human immunodeficiency virus (hiv) , library science , sociology , media studies , political science , law , viral disease , computer science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom